Table 1.
Clinical characteristics of the CCD + and CCD− groups
| CCD + | CCD− | P value | |
|---|---|---|---|
| Age | 46(12) | 54(14) | 0.300 |
| Male (%) | 13(93) | 8(80) | 0.550 |
| Preprocedural, median (IQR) | |||
| Blood glucose (mmol/L), median (IQR) | 6.00(0.85) | 6.00(0.85) | 1.000 |
| Injection activity (MBq) | 302.11(53.00) | 295.08 (87.67) | 0.403 |
| Size of infarction, median (IQR) | 962.50(1820.00) | 44.00(112.75) | <0.001 |
| Baseline | |||
| NIHSS score, median (IQR) | 1.0(1.0) | 0.0(1.0) | 0.013 |
| mRS score, median (IQR) | 1.0(1.5) | 0.0(1.5) | 0.048 |
| Follow-up | |||
| NIHSS score, median (IQR) | 0.0(1.0) | 0.0(0.0) | 0.172 |
| mRS score, median (IQR) | 0.0(0.5) | 0.0(0.0) | 0.625 |
CCD crossed cerebellar diaschisis; CBF cerebral blood flow; AI asymmetry index; IQR interquartile range